Our guest speaker, Richa Singhania, Ph.D., Director, Brain Organoid Core at Weill Cornell Medicine covers the following:
Stem cell models of human brain: 1:54 - 4:37
Cerebral organoids overview: 4:38 - 9:19
Advances in brain organoid technology: 9:20 - 21:29
Next generation organoid models: 21:30 - 27:39
Applications of brain organoids in disease modeling: 27:40 - 29:54
Modeling Glioblastoma in brain organoids: 29:54 - 43:24
Understanding neurological effects of viruses: 43:25 - 46:22
SARS-Cov-2 infection of brain organoids: 46:23 - 49:00
The promise of brain organoids: 49:11 - 54:11
Q&A Session: 54:12 - 1:01:04
Speaker Bio:
Richa is passionate about bringing precision medicine to the masses and make preclinical research successful to ultimately improve the lives of people affected by cancer. Richa has over 10 years of experience in translational cancer research, and her latest research is based on using stem cells and organoids for cancer modeling and drug discovery. Richa obtained a Masters in Biotechnology and PhD in Molecular Biology from University of Queensland, Australia. Thereafter, she completed postdoctoral fellowships at academic institutions in USA and UK. Currently, she is spearheading the Starr Foundation Cerebral Organoid Translational Core at Weill Cornell Medicine, New York which integrates latest advances in organoid and automation technologies to create personalized solutions for brain cancer patients.